Unlocking the potential of asymmetric hydrogenation at Merck.
about
A theoretically-guided optimization of a new family of modular P,S-ligands for iridium-catalyzed hydrogenation of minimally functionalized olefins.Cobalt precursors for high-throughput discovery of base metal asymmetric alkene hydrogenation catalysts.Natural products as inspiration for the development of asymmetric catalysis.Asymmetric homogeneous hydrogenations at scale.Rhodium-catalysed asymmetric hydrogenation as a valuable synthetic tool for the preparation of chiral drugs.Looking forward in pharmaceutical process chemistry.Chemistry informer libraries: a chemoinformatics enabled approach to evaluate and advance synthetic methods.Practical High-Throughput Experimentation for ChemistsHighly efficient Rh(I)-catalyzed asymmetric hydrogenation of beta-amino acrylonitriles.New pentacoordinated rhodium species as unexpected products during the in situ generation of dimeric diphosphine-rhodium neutral catalysts.Homoleptic iron(ii) and cobalt(ii) bis(phosphoranimide) complexes for the selective hydrofunctionalization of unsaturated molecules.Phosphite-Thiother Ligands Derived from Carbohydrates allow the Enantioswitchable Hydrogenation of Cyclic β-Enamides by using either Rh or Ir Catalysts.Simultaneous solvent screening and reaction optimization in microliter slugs.Chiral Rh phosphine–phosphite catalysts immobilized on ionic resins for the enantioselective hydrogenation of olefins in water
P2860
Q30840957-3FF90262-FEA6-48E7-9AE5-71A7C7844AC6Q35056319-B77251C6-718D-4102-B03D-BED1E2D02B9EQ37272545-BD55791F-1160-429D-B009-5BA293211EAAQ37982636-74FD64EE-54AA-42FF-BF9A-C9360C76FF2BQ38058272-173A2BAD-37CE-497F-B382-A8E990993A33Q39957295-C8A21AD1-41BA-4042-BD40-710D8DD6796AQ42115929-5835A593-AFD5-41EE-A775-4744804D8571Q42208730-A8C50D6F-5345-411E-9E99-F394FBCFB426Q43112387-FD4536D0-C69B-4C5A-9499-2A100C65B748Q46838810-06D29C01-1BB9-46F6-BF47-53994D4CFA11Q47769377-D33EEE66-9A80-4638-98BA-89419D02E459Q48304499-338FA7B0-3EF6-4AE8-8ECF-647BD11694D3Q50952641-A31CFD8B-CB38-4034-9C3E-71A581A17072Q57376947-6E5DF667-D9F1-4C06-8F72-BCAE31EE4F5B
P2860
Unlocking the potential of asymmetric hydrogenation at Merck.
description
2007 nî lūn-bûn
@nan
2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Unlocking the potential of asymmetric hydrogenation at Merck.
@ast
Unlocking the potential of asymmetric hydrogenation at Merck.
@en
Unlocking the potential of asymmetric hydrogenation at Merck.
@nl
type
label
Unlocking the potential of asymmetric hydrogenation at Merck.
@ast
Unlocking the potential of asymmetric hydrogenation at Merck.
@en
Unlocking the potential of asymmetric hydrogenation at Merck.
@nl
prefLabel
Unlocking the potential of asymmetric hydrogenation at Merck.
@ast
Unlocking the potential of asymmetric hydrogenation at Merck.
@en
Unlocking the potential of asymmetric hydrogenation at Merck.
@nl
P356
P1476
Unlocking the potential of asymmetric hydrogenation at Merck.
@en
P2093
C Scott Shultz
Shane W Krska
P304
P356
10.1021/AR700141V
P407
P577
2007-11-20T00:00:00Z